ArticleWorld journal of urology2026
Efficacy and safety of flexible and navigable suction ureteral access sheath combined with flexible ureteroscopic lithotripsy versus flexible ureteroscopic lithotripsy alone for infected upper urinary tract stones: a retrospective cohort study.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intelligent pressure-guided flexible ureteroscopic lithotripsy improves stone-free rates and reduces infectious complications in upper urinary tract infectious stones.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo compare the efficacy and safety of flexible negative-pressure ureteral access sheath combined with flexible ureteroscopic lithotripsy (FURL) versus FURL alone in the treatment of upper urinary tract infectious stones.
methodsThis retrospective cohort study included 91 patients with upper urinary tract infectious stones (confirmed as struvite or carbonate apatite by postoperative stone composition analysis) who underwent surgery at the First Affiliated Hospital of Xiamen University between January 2023 and January 2025. Based on the surgical approach, patients were divided into two groups: the FANS-UAS combined with FURL group (n = 60) and the FURL alone group (n = 31). Baseline characteristics, stone-free rates (immediate and long-term), and complications were collected and compared between the groups.
resultsCompared to the FURL alone group, the FANS-UAS group had a lower proportion of struvite stones (73.33% vs. 93.55%, P < 0.05) and a lower rate of intraoperative stone basket usage (66.67% vs. 100%, P < 0.05). However, patients in the FANS-UAS group were older, had a larger maximum stone diameter, and higher stone CT values (all P < 0.05). Regarding efficacy and safety: The FANS-UAS group demonstrated a significantly higher immediate stone-free rate (53.34% vs. 12.91%, P < 0.05), but also had a longer operative time, greater estimated intraoperative blood loss, and higher postoperative levels of serum creatinine and cystatin C (all P < 0.05). Concurrently, the FANS-UAS group showed significantly lower rates of systemic inflammatory response syndrome (1.67% vs. 6.45%, P < 0.05), lower hospitalization costs, and a lower rate of postoperative adjuvant therapy (3.33% vs. 45.17%, P < 0.05). However, no statistically significant differences were observed between the two groups in terms of long-term stone-free rate, postoperative pain scores, length of hospital stay, transfusion rate, fever rate, renal pelvis/ureteral injury rate, or reoperation rate (all P > 0.05). Although these differences did not reach statistical significance, the observed numerical trends in some outcomes may hold clinical relevance and warrant further validation through larger-scale studies.
conclusionThe combination of FANS-UAS and FURL is a safe and effective method for treating upper urinary tract infectious stones. Its advantages include a higher immediate stone-free rate, lower hospitalization costs, reduced need for postoperative adjuvant therapy, a lower incidence of sepsis, and faster postoperative recovery, while achieving a long-term stone-free rate comparable to FURL alone. This approach represents a viable new treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.